Moneycontrol
    Moneycontrol PRO

    Latha Venkatesh

    Jump to

    • Sanjiv Bajaj: The bug of entrepreneurship, not just finance, was what drove me

      “Our desire is for Bajaj Finserv to be the financial life cycle partner to every Indian," says Sanjiv Bajaj.

    • From Hesitant Heir to Undisputed Leader: Sanjiv Bajaj's Leadership Story

      Sanjiv Bajaj Explains to @latha_venkatesh his passion for entrepreneurship, how he keeps his team in their toes and India's strengths and challenges as the economy hits inflection point. An exclusive chat for Moneycontrol's Latha & The Leaders

    • Tata Power: A company for all seasons as it sails towards fully integrated solar cell structure

      Tata Power's CEO and MD Praveer Sinha said he is expecting Uttar Pradesh to be the next state government to put out bids for private participation in its discoms

    • Latha & The Leaders: The Secret Sauce Of Dixon's Success

      Atul Lall MD & CEO of Dixon explains to Latha Venkatesh why only one Indian consumer durable maker of the 90's called Weston TV, could evolve into a world beating EMS company in this edition of Latha & The Leaders

    • India, world in need of more power; KEC well poised in T&D segment : Anant Goenka

      India and the world are short on power, what with the growth in data centres and AI. RPG Groyp's flagship KEC International is ideally placed with its expertise in T&D construction, RPG's Vice Chairman, Anant Goenka tells @latha_venkatesh; He sees the newly acquired Camso & the legacy Ceat to grow faster than industry

    • Nestle's Suresh Narayanan sees premiumization, pet-care and wellness powering company back to double digit growth

      Nestle India's outgoing CMD Suresh Narayanan pointed out with justifiable pride that for Nestle SA India is the largest market for Maggie noodles and second-largest for Kitkat in the world.

    • Biocon in a position to be dominant player in diabetes-obesity space: Kiran Mazumdar Shaw

      The Pharma world is seeing a big opportunity in GLP-1s – the new innovative fast emerging drugs for diabetes & obesity. Kiran Mazumdar Shaw believes that with Biocon’s prior mastery over insulins, and its expertise, capacity and scale, it can be a dominant player in this space, even as the branded GPL-Is like semaglutide go off patent.

    • Here are fundamental trading ideas from Basant Maheshwari

    • Here are fundamental trading ideas from Deven Choksey

    • Govt well equipped for better tax compliance: R Gandhi

    • Here are fundamental trading ideas from SP Tulsian

    • Here are some investing picks from market experts

    • UP farm loan waiver: Here's how it will impact PSU banks

    • Here are a few fundamental trading ideas from Sandeep Shenoy

    • Here are some investing picks from market experts

    • FY17 Report Card: A big reset in the economy

    • Here are some fundamental ideas from Deven Choksey

    • Here are some investment picks from market experts

    • Here are fundamental trading ideas from Mayuresh Joshi

    • Here SP Tulsian's fundamental trading ideas

    • Here are some investing picks from market experts

    • Citizen's Monetary Policy panel: RBI to pause on rates

    • Expect dollar to strengthen by August with Fed raising rates: Barry Eichengreen

    • Here are some fundamental trading ideas from Prakash Diwan

    • India's CAD jumps to USD 7.9 billion in Q3

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347